Vitro Diagnostics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 64   

Articles published

VODG 0.0800 0.0000 (0.00%)
price chart
Phosphatidylserine Asymmetry
Speakers: Alan Schroit (UT Southwestern Medical Center), David Ucker (University of Illinois at Chicago), Ari Helenius (ETH H´┐Żnggerberg, Switzerland), Chris Reutelingsperger (Maastricht University, The Netherlands), and Philip E. Thorpe (UT ...
One Lambda Inc. To Be Acquired for $925 Million
“With its strong technology platform, high-margin profile and good growth prospects, the business is perfectly aligned with our specialty in vitro diagnostics strategy.” The San Fernando Valley company was founded in 1984 and has more than 300 employees.
Which Smokers Have Highest Risk Of COPD?
The researchers will also combine metabolic profiling with in vitro studies of human subjects and murine airway epithelium.
Treating Sickle Cell Disease with L-Glutamine
An in-vitro study in the 1990s demonstrated the evidence for increased transport and utilization in sickle cells of glutamine, a common amino acid that is a precursor for NAD.
Clinical Application of miRNAs Remains a Ways Off
In preclinical models of HCC, treatment with anti-miR-21 reduces tumor formation resulting in significant survival benefit. The company's other efforts in oncology include the discovery of miRNA therapeutics for the treatment of glioblastoma multiforme.
Building a Rat That Swims Like a Jellyfish
Researchers have created a synthetic “medusoid” that can propel itself in an electrical field in an aqueous environment. Patricia Fitzpatrick Dimond, Ph.
In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China ...
GlobalData's new report, "In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the In Vitro Diagnostics ...
For New HIV Test, There's No Place Like Home
Jeffrey Conrad Laurence, M.D., editor of AIDS Patient Care and STDs, a journal published by GEN publisher Mary Ann Liebert Inc., told GEN the in-home test should prove valuable in bringing patients to treatment because of its far greater reliability ...
Will Less SOX2 Lead to Brain Cancer Getting Cold Feet?
Reconsidering the “14-Day Rule” Limiting In Vitro Human-Embryo Research. Bioethicists are calling for a reexamination of the internationally recognized rule limiting in vitro research on human embryos to 14 days post-fertilization. Do you favor such a ...
Personalized Medicine: Not Quite There Yet
BIOCOM, the regional life science association representing more than 550 member companies in Southern California, recently invited GEN's Editor-in-Chief, John Sterling, to moderate a breakfast panel discussion in San Diego called The Promise of ...